Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu

Investing In Improving Healthcare in the Commercial Marketplace—featuring Rivka

<a href="https://www.jpmorganchase.com/about/our-business/morgan-health" target="_blank">Morgan Health</a> is focused on improving the quality, equity, and affordability of employer-sponsored healthcare in the U.S. by investing capital in companies focused on improving healthcare in the commercial marketplace. As the Head of Healthcare Innovation at Morgan Health, <a href="https://www.linkedin.com/in/rivka-friedman-4b256640/" target="_blank">Rivka Friedman</a> is focused on improving the quality, equity, and affordability of employer-sponsored healthcare in the U.S. by accelerating the adoption of new approaches to care delivery. On this episode of HLTH Matters, Rivka joins hosts Dr. Jessica Shepherd and Dr. Jordan Shlain to discuss how Morgan Health is working to invest in companies that share their vision of BETTER care. Listen in as Rivka shares how you build trust in the healthcare system and the three things that need to align to improve healthcare for the future. Topics Covered <ul><li>The focus of Morgan health in improving employer-sponsored healthcare</li><li>The key lessons Morgan Health learned from the failed Haven</li><li>Rivka weighs in on the trend of the productization of healthcare</li><li>Rivka shares a few of the companies they are currently working with</li><li>How Morgan Health defines accountable care</li><li>Rivka shares what success looks like for Morgan Health</li><li>The 3 Biggest challenges Morgan Health is facing</li><li>How to build trust in the healthcare system</li><li>Rivka shares what motivates her to keep going to improve healthcare</li></ul> Connect with Rivka Friedman<a href="https://www.linkedin.com/in/rivka-friedman-4b256640/" target="_blank">Rivka on LinkedIn</a><a href="https://www.jpmorganchase.com/about/our-business/morgan-health" target="_blank">Morgan Health</a> Connect with Dr. Jessica Shepherd, Dr. Guatam Gulati &amp; Dr. Jordan Shlain<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/DrShlain" target="_blank">Dr. Shlain on Twitter</a><a href="https://www.linkedin.com/in/drjordanshlain/" target="_blank">Dr. Shlain on LinkedIn</a><a href="https://www.drjessicashepherd.com/about" target="_blank">Dr. Jessica Shepherd MD </a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter </a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a> Resources <a href="https://donellameadows.org/a-visual-approach-to-leverage-points/" target="_blank">A Visual Approach to Leverage Points - The Donella Meadows Project</a><a href="https://emboldhealth.com/" target="_blank">Embold Health</a><a href="https://www.verawholehealth.com/" target="_blank">Vera Whole Health</a><a href="https://centivo.com/" target="_blank">Centivo</a><a href="https://www.letsgetchecked.com/" target="_blank">LetsGetChecked</a>   Introductory Quote[30:18]“One key goal for us across all of our teams is figuring out what works and then scaling it. To do that, we have to try a lot of things and fail. So that&#39;s part of our job, launching these pilots, and then letting a bunch of them not work, and being honest and open both about our successes and our failures.”

S3 Ep23: Investing In Improving Healthcare in the Commercial Marketplace—featuring Rivka Friedman

Head of Health Care Innovation

The Rise of Weight Loss Medications: A Healthcare Trend

Healthcare is complicated, and most people don’t think about it until they need it. In this podcast episode, Saul Marquez welcomes Dr. James Wantuck, the Associate Chief Medical Officer at Accolade, who begins by stating his motivation for entering the healthcare field—a desire to have a significant impact on people&#39;s lives. James delves into the rising popularity of weight management medications, particularly GLP-1s, and the challenges employers face in providing coverage. James shares the results of an extensive survey conducted by Accolade, highlighting the demand for these medications and their potential as a recruitment and retention tool for employees. Finally, Dr. Wantuck emphasizes the importance of the doctor-patient relationship in designing individualized weight management programs and addresses the current medication shortage. Tune in to this discussion to discover the future of weight management and personalized healthcare and how Accolade and PlushCare contribute to this evolving landscape. About James Wantuck:James Wantuck is the Associate Chief Medical Officer at Accolade, where he manages a large, growing group of physicians, therapists, and clinical operations staff while working with patients daily. He&#39;s a board-certified internal medicine physician who co-founded PlushCare in 2015 and grew it to over 200 physicians offering high-quality, accessible, direct-to-consumer virtual care. James earned his Bachelor of Science degree in Chemistry and Neuroscience from the University of Pittsburgh and then earned his doctorate in Medicine at the Vanderbilt University School of Medicine. His mission is to help people at scale. Things You’ll Learn:<ul><li>There is a rising popularity of weight management medication in healthcare.</li><li>GLP-1s are driving the trend when it comes to weight management medications. They are not magic, though.</li><li>Healthcare is complicated, and most people don’t think about it until they need it.</li><li>Hiring a physician with entrepreneurial skills can greatly benefit a healthcare organization.</li><li>Staying responsive to market changes is essential for helping patients access better care.</li></ul>Resources:<ul><li>Connect with and follow James Wantuck on <a href="https://www.linkedin.com/in/jameswantuck/" target="_blank">LinkedIn</a>.</li><li>Follow Accolade on <a href="https://www.linkedin.com/company/accolade-inc-/" target="_blank">LinkedIn</a> and visit their <a href="https://www.accolade.com/?utm_source=linkedin&amp;utm_medium=hero_url" target="_blank">website</a>.</li><li>Learn more about PlushCare on their <a href="https://plushcare.com/" target="_blank">website</a> and follow them on <a href="https://www.linkedin.com/company/plushcare/" target="_blank">LinkedIn</a>.</li><li>The Accolade App has over 17,000 positive reviews. Download it <a href="https://apps.apple.com/us/app/accolade-inc/id1203452254" target="_blank">here</a>.</li></ul>

S4 E10: The Rise of Weight Loss Medications: A Healthcare Trend

Associate Chief Medical Officer

Normalizing Stigmatized Health Issues — featuring Melissa Waters of hims & hers

On this episode of HLTH Matters, Melissa joins Dr. Kuku to explain how Hims &amp; Hers provides care in stigmatized categories like erectile dysfunction and sexual wellness. She shares Hims &amp; Hers’ ambitions around normalizing these stigmatized issues, democratizing access to care, providing price transparency and delivering a high-quality experience. Listen in for insight on Hims &amp; Hers’ stand on access to contraception as a human right and learn how the platform is building trust and credibility with consumers.

S1 Ep6: Normalizing Stigmatized Health Issues — featuring Melissa Waters of hims & hers

Chief Marketing Officer

The Future of Venture Capital in Healthcare—featuring Dr. Vineeta Agarwala

Several years ago, leading VC Marc Andreessen proposed the notion that innovation happens through a process of unbundling and rebundling.  Healthcare is no exception. Through the micro-specialization of companies, we’ve witnessed a great deal of unbundling in the industry. Now, we’ve begun the process of rebundling.  So, what does this mean for the future of healthcare tech? And how do venture investors leverage this idea to decide which digital health startups deserve funding? Dr. Vineeta Agarwala is General Partner at <a href="https://a16z.com/" target="_blank">Andreessen Horowitz</a>, where she leads investments for the a16z bio and health fund across digital health care delivery, biotech and life sciences tools and diagnostics.  Dr. Agarwala has a special interest in companies leveraging unique datasets to improve healthcare delivery, and she serves on several healthcare portfolio company boards, including Memorial Health, Thyme Care and Waymark. On this episode of HLTH Matters, Dr. Agarwala joins host Dr. Guatam Gulati to discuss what health payviders are doing to aggregate the best technology for specialty care and how we might integrate such specialized health tech into already complicated workflows. Dr. Agarwala shares her take on the successes and failures of digital health in the last decade, describing how healthcare tech has been transformative for certain patient populations and why she sees most remote connected wearables as a missed opportunity. Listen in to understand how the high bar for fundraising is changing the way a16z makes decisions and get Dr. Agarwala’s advice for aspiring founders in healthcare tech. Topics Covered <ul><li>How Dr. Agarwala thinks about the unbundling and rebundling of services in healthcare</li><li>What health payviders are doing to aggregate the best possible technology across large numbers of specialty care areas</li><li>How we might integrate specialized health tech into already complicated workflows (and why it’s such a challenge)</li><li>Dr. Agarwala’s take on patients, providers and payers as joint custodians of healthcare data</li><li>The pros and cons of imposing a government tax on corporations to access healthcare data</li><li>How digital health has been transformative for some small patient populations, health systems and provider practices</li><li>Why Dr. Agarwala sees remote connected wearables as a failure in the absence of intelligent care management</li><li>How the high bar for fundraising has changed the way a16z makes healthcare tech investment decisions</li><li>Why a16z is encouraging its portfolio companies to adopt a lean business model</li><li>Why now is a phenomenal time to start a company in the healthcare technology space</li><li>How Dr. Agarwala’s experience with her grandfather’s death informs her work at a16z</li></ul> Connect with Dr. Vineeta Agarwala<a href="https://a16z.com/author/vineeta-agarwala/" target="_blank">Dr. Agarwala at Andreessen Horowitz</a><a href="https://twitter.com/vintweeta" target="_blank">Dr. Agarwala on Twitter</a><a href="https://www.linkedin.com/in/vineeta-agarwala-md-phd-674a591/" target="_blank">Dr. Agarwala on LinkedIn</a> Connect with Dr. Guatam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter </a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn </a> Resources <a href="https://a16z.com/author/julie-yoo/" target="_blank">Julie Yoo at Andreesen Horowitz</a><a href="https://www.thymecare.com/" target="_blank">Thyme Care</a>

S3 Ep2: The Future of Venture Capital in Healthcare—featuring Dr. Vineeta Agarwala

General Partner

Podcast

S3 Ep23: Investing In Improving Healthcare in the Commercial Marketplace—featuring Rivka Friedman

FEATURING